In Information-Gathering Mode, CMS Undecided on Payment Structure for Genetic Tests
July 20, 2011
In Information-Gathering Mode, CMS Undecided on Payment Structure for Genetic Tests
Since genetic tests were not discussed at a public meeting held this week on payment for new codes under the clinical lab fee schedule, "they cannot be priced under the laboratory fee schedule for 2012," a CMS spokesperson said.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- CMS Stance on Reimbursement of Multi-Analyte Algorithm Assays Raises Industry Concerns
September 19, 2012 / Pharmacogenomics Reporter - CMS Seeks Stakeholder Input on Gene Test Reimbursement, Maintains Code Stacking for 2012
June 22, 2011 / Pharmacogenomics Reporter - Industry-Backed Bill Introduced in House as Frustration Grows over CMS Payment Process for MDx
October 3, 2012 / Pharmacogenomics Reporter - Palmetto Issuing 'Z-Codes' to Track Molecular Dx Utilization, Gather Data CPT Codes Can't Provide
November 16, 2011 / Pharmacogenomics Reporter - CMS Issues Pricing for MDx Codes; Labs, Test Developers Still Critical of Rates and Methodology
May 22, 2013 / Pharmacogenomics Reporter